Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Opioid-induced gastrointestinal dysfunction.

Sangeeta R Mehendale1, Chun-Su Yuan

  • 1Department of Anesthesia and Critical Care, Pritzker School of Medicine, University of Chicago, Chicago, IL 60637, USA.

Digestive Diseases (Basel, Switzerland)
|May 16, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Editorial: Bioactive natural products for health: isolation, structural elucidation, biological evaluation, structure-activity relationship, and mechanism, volume II.

Frontiers in chemistry·2026
Same author

Gut bacteria that produce fatty acid ethanolamides alleviate diarrhea-predominant IBS with insulin resistance.

Cell host & microbe·2026
Same author

Editorial: Prevention and treatment of metabolic diseases using bioactive metabolites of herbal medicines also used as foods.

Frontiers in pharmacology·2026
Same author

Gut microbiota drives the metabolic dysregulation in obesity-prone individuals by impairing GDCA-mediated activation of brown adipose thermogenesis and ileal GLP-1 secretion.

Acta pharmaceutica Sinica. B·2026
Same author

A bifunctional monomer molecularly imprinted sensor modified with boronic acid-functionalized carbon dots for detecting azithromycin.

Mikrochimica acta·2025
Same author

Global burden of MASLD-IBD comorbidity from 1990 to 2021 and trend prediction to 2050.

International journal of surgery (London, England)·2025

Opioid analgesics cause gastrointestinal dysfunction, impacting patient quality of life. Understanding these mechanisms aids in developing safer opioids and treatments for opioid-induced bowel dysfunction.

Area of Science:

  • Gastroenterology
  • Pharmacology

Background:

  • Opioid analgesics are widely used for pain management.
  • Opioid-induced gastrointestinal dysfunction (OIGD) is a common and significant side effect.
  • OIGD negatively impacts patients' quality of life.

Purpose of the Study:

  • To review the pathophysiological mechanisms underlying OIGD.
  • To discuss the role of endogenous opioid peptides in gastrointestinal diseases.
  • To highlight the potential for improved treatments based on mechanistic understanding.

Main Methods:

  • Literature review of pathophysiological mechanisms of OIGD.
  • Analysis of the role of endogenous opioid peptides in GI conditions.

Main Results:

Related Experiment Videos

  • Opioid use leads to various gastrointestinal adverse effects.
  • Advanced understanding of OIGD mechanisms has emerged.
  • Endogenous opioid peptides play a role in certain GI diseases.

Conclusions:

  • A deeper comprehension of OIGD pathophysiology is crucial.
  • This knowledge can drive the development of novel opioid analgesics.
  • Improved therapeutic strategies can mitigate OIGD and enhance patient outcomes.